OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

PharmaMar as a Foundational Partner of OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition

The Promise on Hold: Takeda and Pfizer still to respond to help a Nigerian child with Hodgkin Lymphoma

Follicular Lymphoma: EHA 2026 Guidelines Move Chemotherapy-Free Combinations to First Relapse

ALICE Trial at IGCS 2026: Reduced Surgical Morbidity in Endometrial Cancer Staging

What’s New On Radiotherapy of Lung Cancer in 2026?

Oncology News, Insights, Stories by OncoDaily

Take the Chance
OncoDaily Magazine

Take the Chance

UICC
OncoDaily Magazine

How to Become a UICC President

PATINA
Breast Oncology

PATINA: Major FDA–EMA Divide Over Palbociclib in HER2+ Breast Cancer

Pavlos Msaouel: Exploring Metastasis-Directed Radiation in the Treatment of SMARCB1-Deficient Renal Medullary Carcinoma?

Research and Advocacy Opportunity - Pancreatic Cancer Ireland Patient and Family Experience Survey

Sunvozertinib (ZEGFROVY) Now Available in the US for Post-Platinum EGFR Exon 20 Insertion NSCLC

Could a Mentor Help you Take the Next Step in Your Oncology Career? - ESO

KRAS Mutant NSCLC in 2026: From G12C Inhibition to RAS(ON), Pan-RAS and Combination Strategies

monarchE: Abemaciclib Benefit Persists Across Nodal Subgroups in High-Risk HR+/HER2− Early Breast Cancer

Partha Basu: Breast Cancer Biomarker Testing in Low-Resource Settings

Voices
Anne-Claire Gerbaldi

Anne-Claire Gerbaldi։ Three AI Announcements in a Week, One Vision for AI at AstraZeneca

Elizabeth Smyth: ESMO Updates Clinical Practice Guidelines for Gastric and Oesophageal Cancer

JJ Singleton Shares Experience at PCORI Annual Meeting and Highlights Lessons From Patient-Centered Clinical Research

Federica Miglietta: CNS and Leptomeningeal Involvement in Advanced Breast Cancer

Could AI Help Predict Breast Cancer Risk Years Before a Diagnosis? - BCRF

ESMO Introduces Updated ESCAT v2 Framework to Guide Precision Oncology Treatment Decisions

Vivek Subbiah: Joining the International Alliance for Personalised Medicine Event at ESMO 2026

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ESSO - Advanced Course on Breast Cancer Surgery

22 Oct
Breast Cancer Surgery

ESSO - Advanced Course on Pancreatic Cancer Surgery

European Society of Surgical Oncology

22 Oct
Pancreatic Cancer Surgery

6th European Congress on Cancer and Oncology Research - UICC

Coalesce Research Group

22 Oct
Cancer and Oncology Research

64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026)

Japan Society of Clinical Oncology

22 Oct
Japan Society of Clinical Oncology

50th International Conference on Screening for Lung Cancer and 18th Conference on Research for Early Lung Cancer Treatment

International Early Lung Cancer Action Program

22 Oct
Lung Cancer

2026 Accelerated Review in Medical Oncology

Memorial Sloan Kettering Cancer Center (MSK)

23 Oct
Accelerated Review in Medical Oncology

The OSMO Fall 2026 Membership Conference

Oregon Society of Medical Oncology

23 Oct
OSMO Fall 2026

The 37th Annual Fall Foliage Cancer Conference

Continuing Cancer Education, Inc

23 Oct
Fall Foliage Cancer

Developing New Services in Radiation Medicine: Implementation, Innovation, and Integration

UPMC Center for Continuing Education in the Health Sciences

23 Oct
Radiation Medicine

IMOS Fall Medical Meeting 2026

Illinois Medical Oncology Society

23 Oct
IMOS Fall Medical Meeting

Immune-oncology
Pembrolizumab: What Determines Response to PD-1 Blockade?

Pembrolizumab: What Determines Response to PD-1 Blockade?

PD-1 Bispecific Antibodies: One Molecule or Two Drugs?

ESMO 2026: 5 Phase III Immunotherapy Trials to Watch

ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC?

Can Live Tumor Biopsies Predict Immunotherapy Response?

KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

Gastrointestinal-Oncology
ESMO 2026 colorectal cancer

11 Colorectal Cancer Trials to Watch at ESMO 2026

ESMO 2026 Guideline: Key Updates in Gastric and Esophageal Cancer Management

FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer

10 Must-Read Posts In GI Oncology This Week

3D Models and Tissue Engineering for Colorectal Cancer Drug Screening

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

Breast-Oncology
PATINA

PATINA: Major FDA–EMA Divide Over Palbociclib in HER2+ Breast Cancer

monarchE: Abemaciclib Benefit Persists Across Nodal Subgroups in High-Risk HR+/HER2− Early Breast Cancer

Breast Cancer in Algeria in 2026: Can Access Keep Up With Therapeutic Progress?

Beyond CDK4/6: Next-Generation CDK Inhibitors Aim to Overcome Resistance in HR+/HER2− Breast Cancer

Premenopausal HR+/HER2− Early Breast Cancer: Where Evidence Still Falls Short in Adjuvant Care

ESMO 2026: 10 Breast Cancer ADCs to Watch in Madrid

HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC

Lung-Oncology
ZEGFROVY

Sunvozertinib (ZEGFROVY) Now Available in the US for Post-Platinum EGFR Exon 20 Insertion NSCLC

KRAS Mutant NSCLC in 2026: From G12C Inhibition to RAS(ON), Pan-RAS and Combination Strategies

RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC

Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease

ESMO 2026: 10 ADCs in Lung Cancer to Watch

FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC

LIGHT-NING: Real-World Nivolumab Plus Ipilimumab Shows Durable Outcomes in Metastatic NSCLC

OncoDaily TV
Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

Not To Miss
UICC

UICC Announces New Board of Directors for 2026–2028

Zainab Shinkafi-Bagudu Assumes the Role of UICC President

C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term

Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC

ESMO Congress 2028 Heads to Milan: An International Gathering for Cancer Research and Care

20 Posts Not To Miss From ASCOQLTY26

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

OncoGrants
Childhood Cancers

NIH Kids First Program: Genomic Research on Childhood Cancers and Congenital Anomalies

Melanoma Research

Melanoma Research Alliance Established Investigator Award 2026–2027

Technology Impact

CRI Technology Impact Award 2026–2027

Research Scholar Grants

American Cancer Society Research Scholar Grants 2026

Breast Cancer

FY26 Breast Cancer Research Program Breakthrough Award: Levels 1 and 2

NCI

NCI Early-Stage Innovative Cancer Technology Development R61 Grant 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
maryam lustberg

Maryam Lustberg

Oncologists Location New Haven, USA
Natalia Baran

Natalia Baran

Oncologists Location Bern, Switzerland
Aparna Parikh

Aparna Parikh

Oncologists Location Boston, USA
Willem Lybaert

Willem Lybaert

Oncologists Location Sint-Niklaas, Belgium
Robin Zon

Robin Zon

Oncologists Location Cincinnati, USA
Jean-Pierre Armand

Jean-Pierre Armand

Oncologists Location Villejuif, France
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Cathy Eng

Cathy Eng

Oncologists Location Nashville, USA

Drugs Atlas
Bosutinib (Bosulif): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Chronic Myeloid Leukemia Bosutinib (Bosulif) Oct 22, 2026 1:37 am
Nilotinib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Chronic Myeloid Leukemia Nilotinib Oct 22, 2026 1:35 am
Dasatinib (Sprycel): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in CML and Philadelphia Chromosome-Positive ALL Dasatinib (Sprycel) Oct 21, 2026 1:37 am
Imatinib (Gleevec): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in CML, GIST, and Other KIT/PDGFR-Driven Malignancies Imatinib (Gleevec) Oct 20, 2026 1:36 am
Lenvatinib (Lenvima): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Thyroid Cancer, RCC, HCC, and Endometrial Cancer Lenvatinib (Lenvima) Oct 18, 2026 2:06 pm
Regorafenib (Stivarga): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Colorectal Cancer, GIST, and Hepatocellular Carcinoma Regorafenib (Stivarga) Oct 18, 2026 2:05 pm
Sorafenib (Nexavar): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HCC, RCC, and Differentiated Thyroid Cancer Sorafenib (Nexavar) Oct 18, 2026 2:14 am
Pazopanib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Renal Cell Carcinoma and Soft Tissue Sarcoma Pazopanib Oct 18, 2026 2:13 am
Axitinib (Inlyta): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Advanced Renal Cell Carcinoma Axitinib (Inlyta) Oct 18, 2026 2:10 am
Cabozantinib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in RCC, HCC, Thyroid Cancer, and Neuroendocrine Tumors Cabozantinib Oct 18, 2026 2:09 am

OncoDaily Magazine

New Paper Alert
Vinidh Paleri

Vinidh Paleri: Study of Over 30,000 Patients Identifies Key Drivers of Head and Neck Cancer Treatment Delays

Drew Moghanaki

Drew Moghanaki: SBRT as a Non-Surgical Alternative for Pulmonary Nodules

One Biosciences

Uncovering Hidden Drivers of Chemotherapy Resistance in Ovarian Cancer - One Biosciences

Stephen Liu

Stephen Liu on the AMAZE-lung Trial of Amivantamab, Lazertinib, and Bevacizumab in EGFR-Mutant NSCLC

Michael Dickinson,

Michael Dickinson Highlights Outcomes and CNS Relapse Patterns in High-Grade B-Cell Lymphoma

Eduardo Bruera

Eduardo Bruera Highlights Selective Use of Urine Drug Testing in Cancer Pain Clinics

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts